BCL2L1 and triple-negative breast carcinoma: Moreover, since Hsp90 inhibition regulates Akt phosphorylation and Bcl-xL, expression levels of these effector proteins may be suitable predictive of response to Hsp90 inhibition in triple negative breast cancer (Caldas-Lopes et al., 2009).